Neural Cell News Volume 7.49 | Dec 11 2013

    0
    39
    Neural Cell News 7.49 December 11, 2013

    Neural Cell News

         In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
    Cell Therapy News on Facebook  Neural Cell News on Twitter

     
    TOP STORY
    MicroRNA-128 Governs Neuronal Excitability and Motor Behavior in Mice
    Investigators report that microRNA-128 governs motor activity by suppressing the expression of various ion channels and signaling components of the extracellular signal-regulated kinase ERK2 network that regulate neuronal excitability. [Science] Abstract
    Brain Food: NeuroCult SM1 for Long-Term Primary Neuronal Culture. View Data!

     
    PUBLICATIONS (Ranked by impact factor of the journal)
    PKM2 Regulates Chromosome Segregation and Mitosis Progression of Tumor Cells
    The authors showed that tumor-specific pyruvate kinase (PK) M2, but not PKM1, binds to the spindle checkpoint protein Bub3 during mitosis and phosphorylates Bub3 at Y207. This phosphorylation is required for Bub3-Bub1 complex recruitment to kinetochores, where it interacts with Blinkin and is essential for correct kinetochore-microtubule attachment, mitotic/spindle-assembly checkpoint, accurate chromosome segregation, cell survival and proliferation, and active epidermal growth factor receptor-induced brain tumorigenesis. [Mol Cell] Abstract | Press Release

    Therapeutic Activation of Macrophages and Microglia to Suppress Brain Tumor-Initiating Cells
    Investigators found that microglia derived from non-glioma human subjects markedly mitigated the sphere-forming capacity of glioma patient-derived brain tumor-initiating cells in culture by inducing the expression of genes that control cell cycle arrest and differentiation. [Nat Neurosci] Abstract

    MOZ-Mediated Repression of p16INK4a Is Critical for the Self-Renewal of Neural and Hematopoietic Stem Cells
    Researchers showed that the histone acetyltransferase MOZ controls the proliferation of both hematopoietic and neural stem cells by modulating the transcriptional repression of p16INK4a. [Stem Cells] Abstract

    Recruited Brain Tumor-Derived Mesenchymal Stem Cells Contribute to Brain Tumor Progression
    Researchers report the infiltration of mesenchymal stem cell (MSC)-like cells into the GL261 murine glioma model. They showed that the infiltration of brain-tumor (BT) derived MSCs correlates to tumor progression; furthermore, BT-MSCs increased the proliferation rate of GL261 cells in vitro. [Stem Cells] Abstract

    MGARP Regulates Mouse Neocortical Development via Mitochondrial Positioning
    Neocortical development is an extremely complicated process that critically depends on the proper migration, distribution, and positioning of neural cells. Researchers identified mitochondria-localized glutamic acid-rich protein (MGARP) as a negative regulator of neocortical development. [Mol Neurobiol] Abstract

    Transplantation of Neural Stem Cells that Overexpress SOD1 Enhances Amelioration of Intracerebral Hemorrhage in Mice
    Researchers investigated whether genetic manipulation to overexpress copper/zinc-superoxide dismutase (SOD1) enhances survival of grafted neural stem cells and accelerates amelioration of intracerebral hemorrhage. [J Cereb Blood Flow Metab] Abstract

    Glycolysis and Oxidative Phosphorylation in Neurons and Astrocytes During Network Activity in Hippocampal Slices
    Using simultaneous measurements of electrophysiological and metabolic parameters during synaptic stimulation in hippocampal slices from mature mice, researchers showed that neurons and astrocytes use both glycolysis and oxidative phosphorylation to meet their energy demands. [J Cereb Blood Flow Metab] Abstract

    Selective Vulnerability of Spinal and Cortical Motor Neuron Subpopulations in delta7 SMA Mice
    The authors investigated, using stereological quantification methods, the spinal cord and cerebral motor cortex of delta7 spinal muscular atrophy (SMA) mice during development, to verify extent and selectivity of motor neuron loss. [PLoS One] Full Article

    Effects of Heat Shock on Survival, Proliferation and Differentiation of Mouse Neural Stem Cells
    Researchers examined the effects of heat shock on homogeneous proliferating neural stem cells (NSCs) derived from mouse embryonic stem cells. After heat shock at 42°C for 20 minutes, the proliferating NSCs continued to proliferate, although subtle changes were observed in gene expression and cell survival and proliferation. [Neurosci Res] Abstract

    1-Methyl-4-Phenylpyridinium-Induced Cell Death via Autophagy Through a Bcl-2/Beclin 1 Complex-Dependent Pathway
    The authors hypothesized that the 1-methyl-4-phenylpyridinium (MPP+) toxicity generally associated with initiating the apoptotic signaling cascade also increases an autophagic phenotype in neuronal cells. Using the SK-N-SH dopaminergic cell lines, they demonstrated that MPP+ increases the expression of microtubule-associated protein light chain 3, an autophagosome membrane marker and the mTOR signaling pathway, and Beclin 1 while decreasing the Bcl-2 levels. [Neurochem Res] Abstract

    Your Free Copy of the Nature Neuroscience Poster

     
    REVIEWS
    Neural Stem Cell Therapies for Enteric Nervous System Disorders
    The authors discuss enteric neuropathies that might be targets for stem cell therapies and the barriers that could limit treatment application. [Nat Rev Gastroenterol Hepatol] Abstract

    Human Stem Cell Models of Neurodegeneration: A Novel Approach to Study Mechanisms of Disease Development
    The authors provide an overview of human stem cell models of neurodegeneration using induced pluripotent stem cells from patients with Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, frontotemporal dementia, Huntington’s disease, spinal muscular atrophy and other neurodegenerative diseases. [Acta Neuropathol] Abstract

    Visit our reviews page to see a complete list of reviews in the neuroscience field.

     
    INDUSTRY NEWS
    AstraZeneca and Lieber Institute for Brain Development Announce Neuroscience Collaboration
    AstraZeneca announced that it has entered into a two-year research collaboration with the Lieber Institute for Brain Development to use genetics and stem cell biology to discover new drugs for neuropsychiatric and neurodevelopmental disorders such as autism and schizophrenia. [Lieber Institute for Brain Development]
    Press Release

    DioGenix Raises $3.2 Million for Novel Molecular Diagnostic for Multiple Sclerosis, MSPrecise
    DioGenix, Inc. announced that it raised $3.2 million in a private financing consisting of new individual investors and returning investors including life sciences fund Nerveda, LLC. The financing follows recent interim results from a prospective clinical trial of DioGenix’ MSPrecise®, a next-generation sequencing assay, which continues to show that it can accurately identify patients with multiple sclerosis at first clinical presentation. [DioGenix, Inc.] Press Release

    From our sponsor:
    Looking for ALDH+ cancer stem cells? Watch a video to see how ALDEFLUORTM can help.

     
    POLICY NEWS
    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)

     
    EVENTS
    NEW Canadian Association for Neuroscience 2014
    May 25-28, 2014
    Montreal, Canada

    NEW Gordon Research Conference: Cell Biology of the Neuron
    January 22-27, 2014
    Waterville Valley, United States

    Visit our events page to see a complete list of events in the neural cell community.

     
    JOB OPPORTUNITIES
    NEW Postdoctoral Position – Modelling Neurodegenerative and Neuropsychiatric Diseases Using iPSCs and Neural Differentiation (University of Duesseldorf)

    NEW Postdoctoral Position – Presynaptic Mechanisms of Plasticity and Optogenetic Modulation of Transcription and Neural Homeostasis (Istituto Italiano di Tecnologia)

    Clinical MD – Clinical Development Program for Oncology and Autoimmune Diseases (Immunomedics, Inc.)

    Chief Medical Officer – Novel Therapeutics in Oncology and Autoimmune Disease (Immunomedics, Inc.)

    Postdoctoral Position – Neural Stem Cell and Developmental Neurobiology (Cincinnati Children’s Hospital Medical Center)

    Postdoctoral Position – Neuroimaging (BarcelonaBeta Brain Research Center)

    PhD Studentship – Genetic Susceptibility to Neurodegenerative Brain Diseases (University of Antwerp)

    Postdoctoral Fellow – Neuroscience (Harvard Medical School)

    Scientist – Particle Chemistry (STEMCELL Technologies Inc.)

    Research Technologist – Human Pluripotent Stem Cell Products (STEMCELL Technologies Inc.)

    Research Associate/Scientist – Antibodies Group (STEMCELL Technologies Inc.)


    Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

     

    Have we missed an important article or publication in Neural Cell News? Click here to submit!

    Comments or Suggestions? Email info@connexoncreative.com with your feedback.

    Learn more about Neural Cell News: Archives | Events | Contact Us